XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
29 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

XTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The companys pipeline products comprise hCDR1 peptide and recombinant erythropoietin (rHuEPO). Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus (SLE); and rHuEPO is a compound developed to prolongate multiple myeloma advanced-stage patients' survival. The company offers identifying, validating and in-licensing of therapeutic candidates. It provides partnerships and collaborations with various companies to develop and market its products in Israel and abroad. XTL is headquartered in Raanana, Israel

XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the ke

  
Source:
Document ID
GDPH42332D
Country
Industry
Ticker
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
XTL Biopharmaceuticals Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
XTL Biopharmaceuticals Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
XTL Biopharmaceuticals Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
XTL Biopharmaceuticals Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
XTL Biopharmaceuticals Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
XTL Biopharmaceuticals Ltd., Pharmaceuticals &Healthcare, Deal Details1115
  Licensing Agreements111
    XTL Biopharma Enters into Licensing Agreement with CyDex Pharma111
    XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1121
    XTL BioPharma Terminates Licensing Agreement with Presidio Pharma131
    XTL BioPharma Announces Licensing Agreement With Mor Research Applications141
    XTL Biopharma Enters into Licensing Agreement with Yeda Research and Development151
    Xtl Biopharma Terminates Licensing Agreement With Dov Pharma161
  Equity Offering171
    XTL Biopharma Prices Private Placement of American Depositary Shares to Raise USD4 Million171
    XTL Biopharma Completes Private Placement Of Shares For US$1.1 Million Upon Exercise Of Warrants181
    XTL Biopharma Completes Private Placement Of Securities For US$2.4 Million191
  Acquisition201
    Zmiha Investment House Acquires 45% Stake In Proteologics For US$3.4 Million201
    XTL Biopharma Acquires 31% Stake In Proteologics From Teva For US$2 Million211
    XTL Biopharma To Acquire Kitov Pharma, Drug Development Company222
    XTL BioPharma Completes Acquisition Of MinoGuard241
    XTL BioPharma Acquires BioGAL251
XTL Biopharmaceuticals Ltd. - Key Competitors261
Key Employees271
Locations And Subsidiaries281
  Head Office281
  Other Locations &Subsidiaries281
Appendix291
  Methodology291
  About GlobalData291
  Contact Us291
  Disclaimer291

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/XTL-Biopharmaceuticals-Ltd-XTLB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7861>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/XTL-Biopharmaceuticals-Ltd-XTLB-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7861>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research